Leuven-based investment management firm Capricorn Partners has launched the Capricorn Healthtech Fund II with a first closing of €51 million to support digital health and medtech startups across Europe. The fund aims to reach €100 million.
- Launched in 1993 by Jos B. Peeters, Capricorn Partners is an independent pan-European venture capital firm that invests in innovative companies using technology as a competitive advantage.
- The firm manages funds in sectors like sustainable chemistry, digital growth, ICT, healthtech, cleantech, and industrial biotech, leading to successful exits such as Cartagenia, Bluebee, Sequana Medical, and icometrix.
- The new fund aims to support both traditional medical devices and innovative health software platforms and applications across Europe, with a focus on the Benelux region.
- The Capricorn Healthtech Fund II plans to invest in 10 to 15 companies at the late seed to Series B stages, with initial investments ranging from €1 million to €5 million.
“With Capricorn Healthtech Fund II, we invest in healthcare transformers and facilitate their integration into mainstream healthcare practices, making healthcare more accessible and efficient” Claims Filip Pintelon, Investment Partner Health.
- The Capricorn Healthtech Fund II is supported by new and existing investors, including Invest-NL, focused on healthcare innovation, and Sensinnovat, dedicated to healthtech solutions.
“We are excited to partner with Capricorn Healthtech Fund II, as it aligns with our commitment to investing in healthtech solutions that improve lives and strengthen healthcare systems worldwide," Explains Geert Reynders, Chief Investment Officer at Sensinnovat.
- Existing investors, include Quest for Growth, AG Insurance/Ageas, PMV, finance&invest.brussels, and KU Leuven Research & Development. Additionally, COI is supporting the fund to promote digital innovation in Flanders.
